Issa, Hasan http://orcid.org/0000-0002-9760-9618
Bhayadia, Raj http://orcid.org/0000-0003-0865-9582
Winkler, Robert http://orcid.org/0009-0009-5470-1324
Swart, Laura Elise
Heckl, Dirk
Klusmann, Jan-Henning http://orcid.org/0000-0002-1070-0727
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (714226)
Wilhelm Roux Program of Martin-Luther-University Halle-Wittenberg Hilfe für krebskranke Kinder Frankfurt e.V.
Article History
Received: 16 February 2023
Revised: 6 May 2023
Accepted: 31 May 2023
First Online: 13 June 2023
Competing interests
: J-HK has advisory roles for Bluebird Bio, Novartis, Roche and Jazz Pharmaceuticals. H Issa and L-E Swart are inventors on a patent for targeted lipid nanoparticle formulations (W02023048572) granted to Princess Máxima Center for Pediatric Oncology.